ピーナッツアレルギー治療の世界市場2023-2030:市場規模、シェア、動向分析

◆英語タイトル:Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書(GRV23AUG062)◆商品コード:GRV23AUG062
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2023年7月25日
◆ページ数:180
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ピーナッツアレルギー治療市場の成長と動向
Grand View Research社の最新レポートによると、ピーナッツアレルギー治療の世界市場規模は2030年までに9億9,220万米ドルに達する見込みです。同市場は2023年から2030年にかけてCAGR 10.44%で成長する見込みです。市場成長を促進する主な要因としては、堅調な製品パイプライン、高い疾患罹患率、薬物送達システムの進歩、主要企業による戦略的イニシアティブなどが挙げられます。

市場の主要企業は、さまざまな戦略を通じてピーナッツアレルギー治療のパイプラインを強化しています。例えば、アラバックスは2022年12月にシリーズBの資金調達ラウンドを開始し、オーストラリアの著名なヘルスケア起業家であるTenmileとBrandon Capitalから2,000万米ドルの投資を獲得しました。この資金調達により、アラバックスはピーナッツにアレルギー反応を起こす人を対象としたPVX108の第II相臨床試験を開始する予定です。このような資金調達により、研究開発プログラムの進展が期待されます。

市場は、ピーナッツアレルギー治療薬の承認件数の増加によって刺激されています。2020年1月、米国食品医薬品局(FDA)は、Aimmune Therapeutics, Inc.が開発したPALFORZIA [Peanut (Arachis hypogaea) Allergen Powder-dnfp]を認可しました。PALFORZIAは、ピーナッツアレルギーの患者さんに対して承認された初めての免疫療法薬です。本剤は、ピーナッツの誤食によるアナフィラキシーを含むアレルギー反応を軽減することを目的とした経口免疫療法剤です。本薬は、アレルギーが確認された方を対象としており、4歳から17歳の小児には初回投与量の増量が推奨されています。

2023年第1四半期現在、いくつかの有望なパイプライン製品が臨床開発中です。DBVテクノロジーズのViaskin Peanut、DupixientのCA002、サノフィとリジェネロンの共同開発であるCamallegrなどです。さらに、ADP101、VE416、INP20、CNP-201などの資産も開発中です。これらの薬剤の導入は、予測される予測期間中の市場の成長と拡大に貢献すると予想されます。

ピーナッツアレルギー治療市場レポートハイライト

- エピネフリン部門が2022年の主要市場シェアを獲得 アナフィラキシー治療の標準はエピネフリン自動注射器であり、緊急時のアレルギー管理にも不可欠です。

- 投与経路別では、注射剤が2022年に市場を席巻しました。これは、患者中心の治療が重視されるようになり、患者にとって実用的で痛みが少なく、使いやすい注射剤の開発が進められているためです。これには、ウェアラブル技術や自動注射器などの注射療法の代替デリバリーシステムの検討も含まれます。

- 流通チャネル別では、病院薬局セグメントが2022年に最大の市場シェアを占めました。病院薬局はピーナッツアレルギーの患者へのサポートや情報提供に重点を置いています。

- 北米は同市場において確固たる地位を確立しています。これは、遺伝子治療、生物製剤、その他の免疫調節介入など、ピーナッツアレルギーの根本的な原因に対処するための新たな治療戦略を現在研究している数多くの製薬会社、学術機関、研究機関が存在するためです。

- 主な市場参入企業には、サノフィ、Aimmune Therapeutics Inc.、DBV Technologies、Vedanta Biosciences, Inc.、Alladapt Immunotherapeutics, Inc.、Regeneron Pharmaceuticals Inc.、Aravax Pty Ltd.、Prota Therapeutics、Teva Pharmaceuticals Industries Ltd.などがあります。

第1章. 調査手法&範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 投与経路別分析
第5章. 薬剤クラス別分析
第6章. 流通チャネル別分析
第7章. 地域別分析
第8章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Market Definitions
1.2. Objectives
1.2.1. Objective – 1
1.2.2. Objective – 2
1.2.3. Objective – 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Gvr’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information Or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Drug Class and Route of Administration Snapshot
2.3. Distribution Channel Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Rising product approvals for the treatment of peanut allergy
3.4.2. Increasing prevalence of peanut allergies
3.4.3. Increasing healthcare expenditure
3.5. Market Restraint Analysis
3.5.1. High cost of the treatment and the products
3.6. Business Environment Analysis
3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2. Porter’s Five Forces Analysis
3.7. COVID-19 Impact Analysis
Chapter 4. Route Of Administration Business Analysis
4.1. Peanut Allergy Treatment Market: Route Of Administration Movement Analysis
4.2. Oral
4.2.1. Oral Market, 2018 – 2030 (USD Million)
4.3. Injectable
4.3.1. Injectable Market, 2018 – 2030 (USD Million)
4.4. Others
4.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Drug Class Business Analysis
5.1. Peanut Allergy Treatment Market: Drug Class Movement Analysis
5.2. Antihistamines
5.2.1. Antihistamines Market, 2018 – 2030 (USD Million)
5.3. Epinephrine
5.3.1. Epinephrine Market, 2018 – 2030 (USD Million)
5.4. Immunotherapies
5.4.1. Immunotherapies Market, 2018 – 2030 (USD Million)
5.5. Others
5.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 6. Distribution Channel Business Analysis
6.1. Peanut Allergy Treatment Market: Distribution Channel Movement Analysis
6.2. Hospital Pharmacy
6.2.1. Hospital Pharmacy Market, 2018 – 2030 (USD Million)
6.3. Retail Pharmacy
6.3.1. Retail Pharmacy Market, 2018 – 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Peanut Allergy Treatment Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Peanut Allergy Treatment Market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. Reimbursement Scenario
7.2.3.6. U.S. Peanut Allergy Treatment market, 2018 – 2030 (USD MILLION)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Reimbursement Scenario
7.2.4.6. Canada Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. SWOT Analysis
7.3.2. Europe Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Reimbursement Scenario
7.3.3.6. Germany Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.4. UK
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. Reimbursement Scenario
7.3.4.6. UK Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.5. France
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Reimbursement Scenario
7.3.5.6. France Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.6. Italy
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Reimbursement Scenario
7.3.6.6. Italy Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.7. Spain
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Reimbursement Scenario
7.3.7.6. Spain Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.8. Denmark
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Reimbursement Scenario
7.3.8.6. Denmark Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Reimbursement Scenario
7.3.9.6. Sweden Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.3.10. Norway
7.3.10.1. Key Country Dynamics
7.3.10.2. Target Disease Prevalence
7.3.10.3. Competitive Scenario
7.3.10.4. Regulatory Framework
7.3.10.5. Reimbursement Scenario
7.3.10.6. Norway Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. SWOT Analysis
7.4.2. Asia Pacific Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. Reimbursement Scenario
7.4.3.6. Japan Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4.4. China
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. Reimbursement Scenario
7.4.4.6. China Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4.5. India
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Reimbursement Scenario
7.4.5.6. India Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4.6. South Korea
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Reimbursement Scenario
7.4.6.6. South Korea Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4.7. Australia
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Scenario
7.4.7.6. Australia Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.4.8. Thailand
7.4.8.1. Key Country Dynamics
7.4.8.2. Target Disease Prevalence
7.4.8.3. Competitive Scenario
7.4.8.4. Regulatory Framework
7.4.8.5. Reimbursement Scenario
7.4.8.6. Thailand Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. SWOT Analysis
7.5.2. Latin America Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.5.3. Brazil
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Reimbursement Scenario
7.5.3.6. Brazil Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Reimbursement Scenario
7.5.4.6. Mexico Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.5.5. Argentina
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Competitive Scenario
7.5.5.4. Regulatory Framework
7.5.5.5. Reimbursement Scenario
7.5.5.6. Argentina Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. SWOT Analysis
7.6.2. MEA Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.6.3. South Africa
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Reimbursement Scenario
7.6.3.6. South Africa Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.6.4. Saudi Arabia
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. Reimbursement Scenario
7.6.4.6. Saudi Arabia Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.6.5. UAE
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Reimbursement Scenario
7.6.5.6. UAE Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
7.6.6. Kuwait
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Competitive Scenario
7.6.6.4. Regulatory Framework
7.6.6.5. Reimbursement Scenario
7.6.6.6. Kuwait Peanut Allergy Treatment market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant’s overview
8.2. Financial performance
8.3. Participant categorization
8.3.1. Market Leaders
8.3.2. Peanut Allergy Treatment market Share Analysis, 2022
8.3.3. Company Profiles
8.3.3.1. Sanofi
8.3.3.1.1. Company Overview
8.3.3.1.2. Financial Performance
8.3.3.1.3. Product Benchmarking
8.3.3.1.4. Strategic Initiatives
8.3.3.2. Aimmune Therapeutics Inc.
8.3.3.2.1. Company Overview
8.3.3.2.2. Financial Performance
8.3.3.2.3. Product Benchmarking
8.3.3.2.4. Strategic Initiatives
8.3.3.3. DBV Technologies
8.3.3.3.1. Company Overview
8.3.3.3.2. Financial Performance
8.3.3.3.3. Product Benchmarking
8.3.3.3.4. Strategic Initiatives
8.3.3.4. Vedanta Biosciences, Inc.
8.3.3.4.1. Company Overview
8.3.3.4.2. Financial Performance
8.3.3.4.3. Product Benchmarking
8.3.3.4.4. Strategic Initiatives
8.3.3.5. Alladapt Immunotherapeutics, Inc.
8.3.3.5.1. Company Overview
8.3.3.5.2. Financial Performance
8.3.3.5.3. Product Benchmarking
8.3.3.5.4. Strategic Initiatives
8.3.3.6. Regeneron Pharmaceuticals Inc.
8.3.3.6.1. Company Overview
8.3.3.6.2. Financial Performance
8.3.3.6.3. Product Benchmarking
8.3.3.6.4. Strategic Initiatives
8.3.3.7. Aravax Pty Ltd
8.3.3.7.1. Company Overview
8.3.3.7.2. Financial Performance
8.3.3.7.3. Product Benchmarking
8.3.3.7.4. Strategic Initiatives
8.3.3.8. Prota Therapeutics
8.3.3.8.1. Company Overview
8.3.3.8.2. Financial Performance
8.3.3.8.3. Product Benchmarking
8.3.3.8.4. Strategic Initiatives
8.3.3.9. Teva Pharmaceuticals Industries Ltd.
8.3.3.9.1. Company Overview
8.3.3.9.2. Financial Performance
8.3.3.9.3. Product Benchmarking
8.3.3.9.4. Strategic Initiatives
8.3.4. Strategy Mapping
8.3.4.1. Expansion
8.3.4.2. Acquisition
8.3.4.3. Collaborations
8.3.4.4. Route Of Administration/Drug Class Launch
8.3.4.5. Partnerships
8.3.4.6. Others

List of Tables

Table 1 List of Abbreviations
Table 2 Global Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 3 Global Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 4 Global Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 5 Global Peanut Allergy Treatment Market, by Region, 2018 - 2030 (USD Million)
Table 6 North America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 7 North America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 8 North America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 9 North America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 10 U.S. Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 11 U.S. Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 12 U.S. Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Canada Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 14 Canada Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 15 Canada Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Europe Peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 17 Europe Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 18 Europe peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 19 Europe peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Germany Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 21 Germany Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 22 Germany Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 23 UK Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 24 UK Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 25 UK Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 26 France Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 27 France Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 28 France Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Italy Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 30 Italy Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 31 Italy Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 32 Spain Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 33 Spain Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 34 Spain Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 35 Denmark Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 36 Denmark Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 37 Denmark Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 38 Sweden Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 39 Sweden Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 40 Sweden Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Norway Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 42 Norway Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 43 Norway Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Asia Pacific peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 45 Asia Pacific peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 46 Asia Pacific peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 47 Asia Pacific peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 48 China Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 49 China Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 50 China Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Japan Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 52 Japan Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 53 Japan Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 54 India Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 55 India Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 56 India Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 57 South Korea Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 58 South Korea Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 59 South Korea Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 60 Australia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 61 Australia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 62 Australia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 63 Thailand Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 64 Thailand Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 65 Thailand Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 66 Latin America peanut Allergy Treatment Market, by Country, 2018 - 2030 (USD Million)
Table 67 Latin America peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 68 Latin America peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 69 Latin America peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 70 Brazil Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 71 Brazil Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 72 Brazil Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 73 Mexico Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 74 Mexico Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 75 Mexico Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 76 Argentina Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 77 Argentina Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 78 Argentina Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 83 South Africa Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 84 South Africa Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 85 South Africa Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 89 UAE Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 90 UAE Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 91 UAE Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Kuwait Peanut Allergy Treatment Market, by Route Of Administration, 2018 - 2030 (USD Million)
Table 93 Kuwait Peanut Allergy Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
Table 94 Kuwait Peanut Allergy Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ピーナッツアレルギー治療の世界市場2023-2030:市場規模、シェア、動向分析(Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆